Related Experiment Video

Updated: Aug 23, 2026

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

Histone acetylation regulates p21WAF1 expression in human colon cancer cell lines

Ying-Xuan Chen1, Jing-Yuan Fang, Hong-Yin Zhu

  • 1Renji Hospital, Shanghai Second Medical University, Shanghai Institute of Digestive Disease, Shanghai 200001, China.

World Journal of Gastroenterology
|August 17, 2004
PubMed
Abstract

Insights

Histone acetylation reactivates the p21WAF1 gene in human colon cancer cells, increasing p21WAF1 protein levels. This epigenetic modification offers a potential therapeutic target for colon cancer treatment.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Cancer Research

Background:

  • Histone acetylation is a key epigenetic mechanism influencing gene expression.
  • The p21WAF1 gene plays a crucial role in cell cycle regulation and tumor suppression.
  • Dysregulation of p21WAF1 is implicated in the development of various cancers, including colon cancer.

Purpose of the Study:

  • To investigate the regulatory role of histone acetylation on p21WAF1 gene expression.
  • To determine the effect of histone deacetylase inhibitors on p21WAF1 expression in human colon cancer cell lines.

Main Methods:

  • Human colon cancer cell lines (Colo-320 and SW1116) were treated with trichostatin or sodium butyrate.
  • Gene expression was analyzed using real-time RT-PCR for mRNA and Western blotting for protein.
  • Histone acetylation levels were assessed via chromatin immunoprecipitation and Western blotting.

Main Results:

  • Treatment with trichostatin or sodium butyrate reactivated p21WAF1 transcription.
  • A significant up-regulation of p21WAF1 protein levels was observed in treated colon cancer cells.
  • Increased histone acetylation was detected in both total cellular chromatin and the p21WAF1 gene-associated chromatin regions.

Conclusions:

  • Histone acetylation is a critical regulator of p21WAF1 gene expression in human colon cancer.
  • Targeting histone acetylation represents a potential therapeutic strategy for colon cancer by modulating p21WAF1.
  • The findings highlight the link between epigenetic modifications and cancer gene regulation.

More Related Videos

Live-imaging of Breast Epithelial Cell Migration After the Transient Depletion of TIP6008:13

Live-imaging of Breast Epithelial Cell Migration After the Transient Depletion of TIP60

Published on: December 7, 2017

Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue09:43

Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue

Published on: November 30, 2018

Related Concept Videos

Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer is an enzyme that can...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3 variants are also...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...